Latest On Perrigo Company plc (PRGO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-08-30 05:53 EST | Dividend | A dividend of $0.28 has been announced on Aug 1, 2024. It will be paid Sep 17, 2024 with an ex-dividend date of Aug 30, 2024. | Neutral |  |
| 2024-05-31 05:52 EST | Dividend | A dividend of $0.28 has been announced on May 1, 2024. It will be paid Jun 18, 2024 with an ex-dividend date of May 31, 2024. | Neutral | |
| 2024-03-07 04:52 EST | Dividend | A dividend of $0.28 has been announced on Feb 26, 2024. It will be paid Mar 26, 2024 with an ex-dividend date of Mar 7, 2024. | Neutral | |
| 2023-11-30 04:52 EST | Dividend | A dividend of $0.27 has been announced on Nov 2, 2023. It will be paid Dec 19, 2023 with an ex-dividend date of Nov 30, 2023. | Neutral | |
| 2023-08-31 05:52 EST | Dividend | A dividend of $0.27 has been announced on Aug 2, 2023. It will be paid Sep 19, 2023 with an ex-dividend date of Aug 31, 2023. | Neutral | |
About Perrigo Company plc (PRGO):
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid read more... 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
General
- Name Perrigo Company plc
- Symbol PRGO
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 11,500
- Last Split Factor2:1
- Last Split Date1993-08-26
- Fiscal Year EndDecember
- IPO Date1991-12-16
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.perrigo.com
Valuation
- Trailing PE 24.33
- Forward PE 15.04
- Price/Sales (Trailing 12 Mt.) 1.11
- Price/Book (Most Recent Quarter) 0.97
- Enterprise Value Revenue 1.66
- Enterprise Value EBITDA 23.39
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $2.82
- Next Year EPS Estimate $3.07
- Next Quarter EPS Estimate $0.98
- Profit Margin -3%
- Operating Margin 9%
- Return on Assets 3%
- Return on Equity -3%
- Revenue 5.06 billion
- Earnings Per Share $1.75
- Revenue Per Share $37.2
- Gross Profit 1.82 billion
- Quarterly Earnings Growth -2.5%
ESG Rating
Highlights
- Market Capitalization 5.52 billion
- EBITDA 860.5 million
- PE Ratio -31.89
- PEG Ratio 2.45
- Analyst Target Price $54.13
- Book Value Per Share $42.49
Share Statistics
- Shares Outstanding 133.1 million
- Shares Float 132.67 million
- % Held by Insiders 75%
- % Held by Institutions 85.61%
- Shares Short 6.48 million
- Shares Short Prior Month 5.99 million
- Short Ratio 3.76
- Short % of Float 7%
- Short % of Shares Outstanding 5%
Technicals
- Beta 1.21
- 52 Week High $57.97
- 52 Week Low $37.98
- 50 Day Moving Average 42.51
- 200 Day Moving Average 45.48
Dividends
- Forward Annual Dividend Rate $0.96
- Forward Annual Dividend Yield 2.34%
- Payout Ratio 23%
- Dividend Date 2021-03-30
- ExDividend Date 2021-03-11
- Dividend Per Share $0.9
- Dividend Yield 3.73%
Perrigo Company plc (PRGO) Dividend Calendar:
Perrigo Company plc pays an annual dividend of $0.96 per share, with a dividend yield of 3.73%.
PRGO's last dividend payment was made to shareholders on March 30, 2021.
Perrigo Company plc pays out 23% of its earnings out as a dividend.
Perrigo Company plc (PRGO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Perrigo Company plc (PRGO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Perrigo Company plc (PRGO) Chart:
Perrigo Company plc (PRGO) News:
Below you will find a list of latest news for Perrigo Company plc (PRGO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Perrigo Company plc (PRGO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest PRGO Trades:
Perrigo Company plc (PRGO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-05 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-11-04 | 8-K (Current report) | |
| 2020-08-17 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-14 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-10 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-08-05 | 8-K (Current report) | |
| 2020-08-05 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-07-06 | 25-NSE (Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret) | |
| 2020-07-06 | 25-NSE (Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-24 | 8-K (Current report) | |
| 2020-06-23 | 11-K (Annual report of employee stock purchase, savings and similar plans) | |
Perrigo Company plc (PRGO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Perrigo Company plc (PRGO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 75%
Institutional Ownership: 8561%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-14 | Robert Willis | EVP & CHRO | Buy | 581.00 | 53.40 | 31,025.40 | 2,358.00 | |
| 2020-08-11 | Svend Andersen | EVP & President CHCI | Buy | 2,828.00 | 53.01 | 149,910.30 | 10,028.00 | |
| 2020-06-29 | Thomas Farrington | EVP and CIO | Buy | 1,398.00 | 54.56 | 76,274.88 | 14,803.00 | |
| 2020-06-29 | Robert Willis | EVP & CHRO | Buy | 270.00 | 54.56 | 14,731.20 | 1,918.00 | |
| 2020-06-29 | Sharon Kochan | EVP, GM International | Buy | 2,285.00 | 54.56 | 124,669.60 | 31,307.00 | |
| 2020-06-29 | Jeffrey Needham | EVP, President CHC Americas | Buy | 2,322.00 | 54.56 | 126,688.32 | 32,149.00 | |
| 2020-06-29 | TODD W KINGMA | Executive VP, General Counsel | Buy | 2,987.00 | 54.56 | 162,970.72 | 40,698.00 | |
| 2020-06-29 | Grainne Quinn | EVP, Chief Medical Officer | Buy | 262.00 | 54.56 | 14,294.72 | 4,796.00 | |
| 2020-06-29 | Ronald Craig Janish | EVP, Global Op. & Supply Chain | Buy | 827.00 | 54.56 | 45,121.12 | 9,429.00 | |
| 2020-06-05 | Robert Willis | EVP & CHRO | Buy | 606.00 | 55.61 | 33,699.66 | 1,964.00 | |
| 2020-05-15 | Adriana Karaboutis | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 10,335.00 | |
| 2020-05-15 | JEFFREY B KINDLER | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 10,863.00 | |
| 2020-05-15 | Bradley A Alford | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 10,866.15 | |
| 2020-05-15 | Geoffrey M. Parker | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 11,347.00 | |
| 2020-05-15 | ROLF A CLASSON | Director | Buy | 7,568.00 | 52.76 | 399,287.68 | 12,366.00 | |
| 2020-05-15 | Donal O'Connor | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 13,343.00 | |
| 2020-05-15 | Theodore R. II Samuels | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 14,290.00 | |
| 2020-05-15 | Erica L Mann | Director | Buy | 6,054.00 | 52.76 | 319,409.04 | 6,054.00 | |
| 2020-05-07 | Thomas Farrington | EVP and CIO | Sell | 100.00 | 52.15 | 5,214.80 | 13,405.00 | |
| 2020-05-07 | Thomas Farrington | EVP and CIO | Sell | 404.00 | 52.14 | 21,064.56 | 13,505.00 | |